Literature DB >> 16024248

Aromatase in endometriosis and uterine leiomyomata.

Serdar E Bulun1, Gonca Imir, Hiroki Utsunomiya, Steven Thung, Bilgin Gurates, Mitsutoshi Tamura, Zhihong Lin.   

Abstract

Endometrial tissue from uterine disease-free women does not exhibit aromatase activity. In contrast, aromatase enzyme activity and mRNA levels are readily detectable in endometriosis. PGE2 stimulates both aromatase expression and activity in endometriotic stromal cells via promoter II region of the aromatase gene. This results in local production of estradiol, which induces PGE2 formation and establishes a positive feedback cycle. This mechanism seems to contribute to continuous production of estradiol and PGE2. Aromatase mRNA levels and enzyme activity are also present in uterine leiomyomata that are estrogen-dependent benign tumors of the myometrium. Successful treatment of endometriosis and uterine leiomyomata using aromatase inhibitors by recent pilot trials underscores the clinical significance of these molecular studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024248     DOI: 10.1016/j.jsbmb.2005.04.012

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  35 in total

1.  Genetic variation in the sex hormone metabolic pathway and endometriosis risk: an evaluation of candidate genes.

Authors:  Britton Trabert; Stephen M Schwartz; Ulrike Peters; Anneclaire J De Roos; Chu Chen; Delia Scholes; Victoria L Holt
Journal:  Fertil Steril       Date:  2011-09-28       Impact factor: 7.329

Review 2.  Estrogen receptors and human disease: an update.

Authors:  Katherine A Burns; Kenneth S Korach
Journal:  Arch Toxicol       Date:  2012-05-31       Impact factor: 5.153

Review 3.  Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.

Authors:  Mostafa A Borahay; Ayman Al-Hendy; Gokhan S Kilic; Darren Boehning
Journal:  Mol Med       Date:  2015-04-13       Impact factor: 6.354

4.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

5.  Aromatase inhibition for refractory endometriosis-related chronic pelvic pain.

Authors:  Fadi Abushahin; Kara N Goldman; Elizabeth Barbieri; Magdy Milad; Alfred Rademaker; Serdar E Bulun
Journal:  Fertil Steril       Date:  2011-08-24       Impact factor: 7.329

Review 6.  The peritoneum--an important factor for pathogenesis and pain generation in endometriosis.

Authors:  Maria-Luisa Barcena de Arellano; Sylvia Mechsner
Journal:  J Mol Med (Berl)       Date:  2014-03-05       Impact factor: 4.599

7.  Aromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons.

Authors:  David Langoi; Mary Ellen Pavone; Bilgin Gurates; Daniel Chai; Asgerally Fazleabas; Serdar E Bulun
Journal:  Fertil Steril       Date:  2012-12-17       Impact factor: 7.329

8.  Steroidogenic enzyme and key decidualization marker dysregulation in endometrial stromal cells from women with versus without endometriosis.

Authors:  L Aghajanova; A Hamilton; J Kwintkiewicz; K C Vo; L C Giudice
Journal:  Biol Reprod       Date:  2008-09-24       Impact factor: 4.285

9.  Conformational selection is present in ligand binding to cytochrome P450 19A1 lipoprotein nanodiscs.

Authors:  Francisco Zárate-Pérez; John C Hackett
Journal:  J Inorg Biochem       Date:  2020-05-21       Impact factor: 4.155

Review 10.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.